إعلان
إعلان
ZBIO
Zenas BioPharma, Inc. Common Stock
16.09
USDبرعاية
-0.32
-1.98%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
16.15
+0.06
+0.40%
تقارير أرباح ZBIO
النسبة الإيجابية المفاجئة
ZBIO تفوق 2 من 5 آخر التقديرات.
40%
التقرير التالي
بيانات التقرير القادم
٠٩ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$39.10M
/-$1.04
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-14.75%
التغير الضمني من Q4 24 (Revenue/ EPS)
+682.00%
/-73.93%
Zenas BioPharma, Inc. Common Stock earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, ZBIO reported earnings of -1.22 USD per share (EPS) for Q3 25, missing the estimate of -1.06 USD, resulting in a -14.17% surprise. Revenue reached --, compared to an expected 10.20 مليون, with a -100.00% difference. The market reacted with a +1.70% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 المحللين forecast an EPS of -1.04 USD, with revenue projected to reach 39.10 مليون USD, implying an نقصان of -14.75% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
What were Zenas BioPharma, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Zenas BioPharma, Inc. Common Stock reported EPS of -$1.22, missing estimates by -14.17%, and revenue of $0.00, -100% below expectations.
How did the market react to Zenas BioPharma, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 1.7%, changed from $35.20 before the earnings release to $35.80 the day after.
When is Zenas BioPharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٩ مارس ٢٠٢٦.
What are the forecasts for Zenas BioPharma, Inc. Common Stock's next earnings report?
Based on 8
المحللين, Zenas BioPharma, Inc. Common Stock is expected to report EPS of -$1.04 and revenue of $39.10M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان